RBC Sciences Financials

0P00007138  CAD 53.17  0.03  0.06%   
Financial data analysis helps to confirm if markets are right now mispricing RBC sciences biologiques. We were able to analyze eleven available financial indicators for RBC Sciences, which can be compared to its peers in the sector. The fund experiences a normal downward trend and little activity. Check odds of RBC Sciences to be traded at C$52.64 in 90 days.
  
Please note that past performance is not an indicator of the future performance of RBC Sciences, its manager's success, or the effectiveness of its strategy. The performance results shown here may have been adversely or favorably impacted by events and economic conditions that may not prevail in the future.

RBC Sciences Fund Summary

RBC Sciences competes with RBC Global, Global Healthcare, and CI Global. To provide long-term capital growth by investing primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances. RBC Life is traded on Toronto Stock Exchange in Canada.
InstrumentCanada Fund View All
ExchangeToronto Exchange
Business Address155 Wellington Street
Fund FamilyRBC Global Asset Management Inc.
Fund CategoryUS Equity
BenchmarkDow Jones Industrial
Phone800 463 3863
CurrencyCAD - Canadian Dollar

RBC Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining RBC Sciences's current stock value. Our valuation model uses many indicators to compare RBC Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RBC Sciences competition to find correlations between indicators driving RBC Sciences's intrinsic value. More Info.
RBC sciences biologiques is rated below average in one year return among similar funds. It also is rated below average in three year return among similar funds reporting about  0.58  of Three Year Return per One Year Return. The ratio of One Year Return to Three Year Return for RBC sciences biologiques is roughly  1.73 . Comparative valuation analysis is a catch-all model that can be used if you cannot value RBC Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for RBC Sciences' Fund. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

RBC sciences biologiques Systematic Risk

RBC Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. RBC Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on RBC sciences biologiques correlated with the market. If Beta is less than 0 RBC Sciences generally moves in the opposite direction as compared to the market. If RBC Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one RBC sciences biologiques is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of RBC Sciences is generally in the same direction as the market. If Beta > 1 RBC Sciences moves generally in the same direction as, but more than the movement of the benchmark.
RBC sciences biologiques is the top fund in net asset among similar funds. Total Asset Under Management (AUM) of US Equity category is currently estimated at about 1.17 Billion. RBC Sciences totals roughly 489.52 Million in net asset claiming about 42% of US Equity category.

RBC Sciences November 27, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of RBC Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of RBC sciences biologiques. We use our internally-developed statistical techniques to arrive at the intrinsic value of RBC sciences biologiques based on widely used predictive technical indicators. In general, we focus on analyzing RBC Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build RBC Sciences's daily price indicators and compare them against related drivers.

Other Information on Investing in RBC Fund

RBC Sciences financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Sciences security.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated